BioNTech SE (BNTX) Inventory Average (2019 - 2025)

BioNTech SE (BNTX) has 6 years of Inventory Average data on file, last reported at $196.4 million in Q4 2025.

• For the quarter ending Q4 2025, Inventory Average fell 38.21% year-over-year to $196.4 million; the trailing twelve-month figure through Dec 2025 stood at $196.4 million (down 38.21% YoY), and the FY2025 full-year result was $213.9 million, down 37.78% from the prior year.
• Inventory Average eased to $196.4 million in Q4 2025, from $262.5 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $545.2 million in Q1 2022 to a low of $126.8 million in Q1 2021.
• A 5-year average of $357.8 million and a median of $370.7 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average surged 329.91% in 2022 and sank 38.21% in 2025, its largest moves.
• Tracing BNTX's Inventory Average over 5 years: stood at $126.8 million in 2021, then jumped by 194.04% to $372.9 million in 2022, then gained by 12.29% to $418.7 million in 2023, then fell by 24.1% to $317.8 million in 2024, then tumbled by 38.21% to $196.4 million in 2025.
• Business Quant data shows BNTX's Inventory Average at $196.4 million in Q4 2025, $262.5 million in Q3 2025, and $264.4 million in Q2 2025.